Clinical Trials Logo

Obsessive-Compulsive Disorder clinical trials

View clinical trials related to Obsessive-Compulsive Disorder.

Filter by:

NCT ID: NCT06466447 Completed - Clinical trials for Obsessive-Compulsive Disorder

Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment

Start date: July 23, 2020
Phase:
Study type: Observational

This is a naturalistic, observational study of children and adolescents with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy.

NCT ID: NCT06466057 Recruiting - Clinical trials for Obsessive-Compulsive Disorder

Metacognitive Therapy for Obsessive-Compulsive Disorder

MCTOCD
Start date: June 11, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn if metacognitive therapy can be effective in a Chinese sample of obsessive compulsive disorder (OCD) . The main questions it aims to answer are: Can metacognitive therapy significantly reduce participants' levels of obsessive-compulsive symptoms? Can metacognitive therapy significantly improve participants' metacognitive adaptations? The researchers will compare metacognitive therapy to a control condition without psychotherapy to see if metacognitive therapy is effective in treating OCD. Participants will: Receive the metacognitive therapy intervention or under control conditions for 8 to 15 weeks. Be assessed for symptoms and metacognitive beliefs at pre-intervention, post-intervention and 12 weeks post-intervention

NCT ID: NCT06443125 Recruiting - Clinical trials for Obsessive-Compulsive Disorder

Study on Therapeutic Mechanism of Natural Psychotherapy for Neurosis

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

explore objective indicators of the efficacy of natural psychotherapy in the treatment of disorders such as obsessive-compulsive disorder

NCT ID: NCT06442527 Not yet recruiting - Clinical trials for Obsessive-Compulsive Disorder

Using Virtual Reality Before Transcranial Magnetic Stimulation for the Treatment of OCD

VR-TMS
Start date: July 2024
Phase: N/A
Study type: Interventional

This study will focus on the use of Virtual Reality (VR) technology in patients receiving treatment using Transcranial Magnetic Stimulation (TMS) for Obsessive-Compulsive Disorder (OCD)

NCT ID: NCT06429488 Completed - Clinical trials for Inflammatory Bowel Diseases

Obsessive-compulsive Disorder, Depression and Anxiety Among Patients With Crohn's Disease

Start date: September 1, 2022
Phase:
Study type: Observational

Introduction: Crohn's disease (CD) and obsessive-compulsive disorder (OCD) are two distinct medical conditions that affect millions of people worldwide. While numerous studies have explored anxiety and depression in CD, there is a notable lack of research about the link between OCD and CD. The aim of the study is to look for a relation between these seemingly unrelated conditions. Methods: Patients with a diagnosis of Crohn's disease were given four different questionnaires in order to assess for the presence of obsessive-compulsive disorder, depression, and anxiety symptoms using the OCI-R score, DASS-21, PHQ-9, and GAD-7. The same questionnaires were used to assess healthy controls for similar symptoms.

NCT ID: NCT06407648 Recruiting - Clinical trials for Obsessive-Compulsive Disorder

Using Personalized Assessments in the Treatment of Childhood OCD

Start date: April 3, 2024
Phase: N/A
Study type: Interventional

The primary purpose of this study is to learn whether personalized assessment of obsessive-compulsive disorder (OCD) symptoms in childhood OCD using mobile health technology are feasible and acceptable for youth and parents. The investigators will also examine whether personalized cognitive-behavioral therapy (CBT) that is informed by personalized OCD assessments yields better clinical outcomes when compared to standard CBT for youth with OCD

NCT ID: NCT06396494 Active, not recruiting - Clinical trials for Obsessive-compulsive Disorder

An Automated Navigation System for Deep Brain Electrode Implantation

Start date: January 1, 2024
Phase:
Study type: Observational [Patient Registry]

1. Analysis of the correlation between imaging and electrophysiological signals. 2. Real time analysis method for optimal implantation position. 3. Simultaneous Imaging and electrophysiology navigation. 4. Accuracy and security verification of navigation system. Expectation(Hypothesis): Develop an automated DBS surgical navigation system based on multimodal brain imaging data and neural electro-physiological signals, which can achieve real-time linkage navigation between imaging and electrophysiology, and automatically generate the optimal implantation position of DBS electrodes based on imaging and electrophysiological information through deep learning algorithms, thereby reducing DBS electrode implantation position errors and improving surgical efficacy.

NCT ID: NCT06376734 Not yet recruiting - Schizophrenia Clinical Trials

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

Searchlight
Start date: June 1, 2024
Phase: Phase 2
Study type: Interventional

Participants will receive Transcranial Magnetic Stimulation (TMS) at a random location in the left prefrontal cortex, excluding sites that are potentially unsafe. Extensive behavioral testing will be conducted to determine which behaviors are modulated by stimulating which circuits.

NCT ID: NCT06370559 Completed - Anxiety Disorders Clinical Trials

Relationship Between Repetitive Negative Thinking and CBT Outcomes

Start date: January 1, 2022
Phase:
Study type: Observational

The goal of this observational study is to learn about the role of repetitive negative thinking (measured by the RTQ) in adult populations from an anxiety disorders and trauma clinic. The main questions it aims to answer are: - Whether the repetitive negative thinking can be used to predict i. initial symptom severity, and ii. therapy outcome (measured by change in scores on disorder specific measures). - Whether change in RTQ mediates change in outcome Participants are sent weekly questionnaires that measure their progress. Within these questionnaires are the RTQ and other disorder-specific measures that we will be analysing. Researchers may also compare clients with different disorders to see the accuracy the RTQ can predict treatment outcomes for each disorder.

NCT ID: NCT06360991 Not yet recruiting - Clinical trials for Obsessive-Compulsive Disorder (OCD)

DBS for Treatment-resistant Obsessive-compulsive Disorder

Start date: April 20, 2024
Phase: N/A
Study type: Interventional

The primary purpose of this study is to investigate the effect of deep brain stimulation (DBS) implantation targeting the anteromedial region of subthalamic nucleus (amSTN), or nucleus accumbens (NAc), or bed nucleus of the stria terminalis (BNST), or ventral capsule/ventral striatum (VC/VS), or the ventral anterior limb of the internal capsule (vALIC) in patients with treatment-resistant obsessive-compulsive disorder (TR-OCD).